Skip header and navigation

15 records – page 1 of 1.

Date Research Question / Title Unique ID Research Team
January 14, 2022 How effective are COVID-19 vaccines? [Evergreen] INF031801v020 ESR Infectious Disease
July 16, 2021 What is known about safety/efficacy of global vaccines not approved in Canada? What are the impacts on international travel and vaccination policies? INF210701 ESR Infectious Disease
June 25, 2021 What is the incidence and duration of long COVID cases? EPM210601 ESR Epidemiology & Modelling
June 25, 2021 What are long COVID's demands on the healthcare system, and its severity of the illness? EPM210602 ESR Epidemiology & Modelling
December 31, 2020 What is the R0 (basic reproduction number) of the new coronavirus variant detected in the UK? INF123001-01 ESR Infectious Disease
December 29, 2020 What is the duration of immunity for COVID-19 in previously infected patients? INF090101v3-01 ESR Infectious Disease
December 15, 2020 How is COVID-19 transmitted from person-to-person and what is the most common source of transmission? INF121501-01 ESR Infectious Disease
September 30, 2020 Is there increased morbidity or mortality peri-operatively for symptomatic, asymptomatic, post-COVID patients? INF092801-01 ESR Infectious Disease
July 21, 2020 What is the accuracy of diagnostic tests for the detection of SARS-CoV-2? EPM072101-01 ESR Epidemiology & Modelling
May 21, 2020 What are the fatality rates associated with COVID-19 for ICU, hospitalized, and patients discharged from ICU to general wards? EPM052101-01 ESR Epidemiology & Modelling
May 21, 2020 What is the mean length of stay for COVID-19 patients in the ICU and general wards? EPM052102-01 ESR Epidemiology & Modelling
May 13, 2020 What proportion of disease transmission is due to persons who are asymptomatic over the entire course of illness? EPM051301-01 ESR Epidemiology & Modelling
May 12, 2020 What are the risk factors for severity and death associated with COVID-19? EPM050901-01 ESR Epidemiology & Modelling
25-Apr-2020 What is the period of communicability of symptomatic SARS-CoV-2? INF042401-01 ESR Infectious Disease
April 9, 2020 What are the best practices for COVID-19 response and control in indigenous populations in Northern Saskatchewan and in on-reserve communities? EPM040901-01 ESR Epidemiology & Modelling

15 records – page 1 of 1.